tirzepatide cardiovascular risk UC Irvine researchers project cardiac benefits from weight-loss medication Tirzepatide cardiovascular event risk assessment:

Observational data presented at ASCO 2026 suggested an association between GLP-1 use and lower metastatic progression in obesity-related cancers, including breast cancer

The Impact of Semaglutide on Eye Health: Balancing Benefits and Risks The diabetes drug semaglutid e has been making headline news ever since the medication received FDA approval for blood sugar control and obesity treatment

If a violation is not correctable or is not verified by the FDA, no close-out letter will be issued

Mizoue T, Inoue M, Tanaka K, Tsuji I, Wakai K, Nagata C, Tsugane S (2006) Tobacco smoking and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population